2 $10 Biotech Stocks To Buy Before The End Of The Week
January 07, 2015 at 05:12 AM EST
Nothing can provide the returns of investing in a small cap biotech or biopharma company. Gilead Sciences is now a biotech juggernaut whose market capitalization is north of $150 billion and has returned over 14,000% in 20 years
